Large Cap High Growth Potential

Results

766

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

766 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$553.48	4.2%	67.2%	US$12.8b	US$678.86	11.3	59.1%	n/a	Pharmaceuticals & Biotech
	GH	US$155.87	-1.6%	241.5%	US$20.7b	US$171.08	19.1	55.8%	n/a	Healthcare
	001389	CN¥158.46	-6.3%	132.7%	CN¥79.8b	CN¥248.67	64.1	32.7%	0.4%	Tech
	002384	CN¥217.73	-8.0%	296.1%	CN¥441.0b	CN¥188.00	194.5	73.1%	0%	Tech
	AXSM	US$230.00	0.8%	109.7%	US$11.8b	US$280.39	16.7	57.0%	n/a	Pharmaceuticals & Biotech
	RHM	€984.20	0.5%	-45.8%	€45.8b	€1,697.85	43.6	30.6%	1.2%	Capital Goods
	LITE	US$732.82	-4.6%	605.7%	US$57.0b	US$1,104.89	129.9	56.3%	n/a	Tech
	NVDA	US$202.81	-0.4%	18.3%	US$4.9t	US$302.31	30.8	22.8%	0.5%	Semiconductors
	SPCX	US$123.99	-10.9%	n/a	US$1.6t	US$240.04	84.6	60.7%	n/a	Telecom
	CRDO	US$202.68	-14.4%	111.7%	US$37.8b	US$276.39	80.0	27.7%	n/a	Semiconductors
	MOD	US$229.34	-2.1%	144.7%	US$12.2b	US$340.86	100.2	49.2%	n/a	Capital Goods
	600183	CN¥123.34	-8.3%	221.1%	CN¥321.3b	CN¥137.08	76.3	28.6%	1.3%	Tech
	688072	CN¥637.05	-24.6%	290.3%	CN¥202.3b	CN¥526.93	112.1	35.2%	0.05%	Semiconductors
	6990	HK$504.00	0%	33.5%	HK$116.3b	HK$558.00	50.6	44.9%	n/a	Pharmaceuticals & Biotech
	002709	CN¥33.41	-10.2%	74.0%	CN¥67.8b	CN¥65.08	23.6	28.9%	0.7%	Materials
	688183	CN¥102.02	-8.1%	101.7%	CN¥84.6b	CN¥159.00	49.2	35.5%	0.9%	Tech
	7769	NT$6,005.00	-10.4%	269.5%	NT$1.1t	NT$9,241.87	74.9	43.1%	1.1%	Semiconductors
	6082	HK$34.46	-19.9%	n/a	HK$84.0b	HK$88.54	70.1	116.9%	n/a	Semiconductors
	2368	NT$927.00	-11.3%	178.8%	NT$468.5b	NT$1,485.00	41.3	38.2%	1.1%	Tech
	6223	NT$5,455.00	-17.8%	398.2%	NT$534.5b	NT$7,684.55	145.2	57.5%	0.4%	Semiconductors
	AMD	US$495.76	-7.2%	215.8%	US$808.4b	US$540.19	163.9	36.2%	n/a	Semiconductors
	MRVL	US$188.68	-13.3%	158.3%	US$165.2b	US$253.69	65.4	25.9%	0.1%	Semiconductors
	NU	US$13.59	-0.6%	5.4%	US$66.1b	US$17.94	5.2	20.0%	n/a	Banks
	BE	US$214.96	-7.9%	747.6%	US$61.1b	US$283.16	10134.9	45.6%	n/a	Capital Goods

Page 1 of 22